161 related articles for article (PubMed ID: 9700979)
1. Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster.
Matsuno H; Kozawa O; Niwa M; Ito T; Tanabe K; Nishida M; Hayashi H; Uematsu T
J Cardiovasc Pharmacol; 1998 Aug; 32(2):191-7. PubMed ID: 9700979
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
[TBL] [Abstract][Full Text] [Related]
3. GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster.
Matsuno H; Kozawa O; Niwa M; Kaida T; Hayashi H; Uematsu T
Br J Pharmacol; 1997 Nov; 122(6):1099-104. PubMed ID: 9480031
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antithrombotic effects and bleeding risk of fractionated aurin tricarboxylic acid and the GPIIb/IIIa antagonist GR144053 in a hamster model of stenosis.
Ito T; Matsuno H; Kozawa O; Niwa M; Sakai N; Uematsu T
Thromb Res; 1999 Jul; 95(1):49-61. PubMed ID: 10403686
[TBL] [Abstract][Full Text] [Related]
5. Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
Thromb Haemost; 2000 Apr; 83(4):605-9. PubMed ID: 10780325
[TBL] [Abstract][Full Text] [Related]
6. tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor.
Nishida M; Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
J Cardiovasc Pharmacol; 2000 Dec; 36(6):770-5. PubMed ID: 11117378
[TBL] [Abstract][Full Text] [Related]
7. Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.
Matsuno H; Kozawa O; Nagashima S; Kanamaru M; Uematsu T
Br J Pharmacol; 1999 Jul; 127(5):1129-34. PubMed ID: 10455258
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
[TBL] [Abstract][Full Text] [Related]
11. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery.
Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T
Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206
[TBL] [Abstract][Full Text] [Related]
12. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.
Rebello SS; Driscoll EM; Lucchesi BR
Stroke; 1997 Sep; 28(9):1789-96. PubMed ID: 9303027
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
Ching S; Thoma A; Monkman S; Kelton JG
Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
[TBL] [Abstract][Full Text] [Related]
15. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.
Rote WE; Werns SW; Davis JH; Feigen LP; Kilgore KS; Lucchesi BR
Cardiovasc Res; 1993 Mar; 27(3):500-7. PubMed ID: 8490951
[TBL] [Abstract][Full Text] [Related]
16. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
Matsuno H; Uematsu T; Umemura K; Takiguchi Y; Wada K; Nakashima M
Br J Pharmacol; 1992 Jul; 106(3):533-8. PubMed ID: 1387025
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
Matsuno H; Kozawa O; Niwa M; Uematsu T
Circulation; 1997 Aug; 96(4):1299-304. PubMed ID: 9286962
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic efficacy of a novel factor Xa inhibitor, FXV673, in a canine model of coronary artery thrombolysis.
Rebello SS; Bentley RG; Morgan SR; Kasiewski CJ; Chu V; Perrone MH; Leadley RJ
Br J Pharmacol; 2001 Aug; 133(7):1190-8. PubMed ID: 11487531
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
